J Korean Med Sci.  2001 Oct;16(5):549-552. 10.3346/jkms.2001.16.5.549.

Identification of a mutation in the human raloxifene response element of the transforming growth factor-3 gene

• Han KO
• Kang YS
• Hwang CS
• Moon IG
• Yim CH
• Chung HY
• Jang HC
• Yoon HK
• Han IK
• Choi YK

• KMID: 2157560
• DOI: http://doi.org/10.3346/jkms.2001.16.5.549

Abstract

The human transforming growth factor-3 (TGF-3) is an important cytokine to maintain bone mass by inhibiting osteoclast differentiation. Recently raloxifene response element (RRE), a new enhancer with a polypurine sequence for estrogen receptor (ER)-mediated gene activation, was identified on the TGF-3 gene. Functional analysis of the RRE-mediated pathway has shown that this would be an important pathway for bone preserving effect. We found a novel mutation in the RRE sequence by single-strand conformational polymorphism analysis in one of 200 Korean women. Cloning and sequencing revealed a heterozygote in which one allele had an insertion of 20 nucleotides (AGAGAGGGAGAGGGAGA GGG) between nucleotide +71 and +72 and a point mutation at nucleotide +75 (G-A transition), and the other allele had normal sequence. The insertion was a nearly perfect tandem duplication of the wild type DNA sequence. The bone mineral density of the affected woman was not much lower than that of age-matched controls. Transient transfection of the mutant allele showed no significantly different activity compared with that of the wild type allele. These observations suggest that the heterozygote variation of the RRE sequence seems not to be operative in determination of bone mass.

Keyword

Transforming Growth Factor-beta3; Raloxifence; Response Elements; Mutation

MeSH Terms

Estrogen Antagonists/*pharmacology
Female
Human
Middle Age
*Mutation
Raloxifene/*pharmacology
*Response Elements
Transfection
Transforming Growth Factor beta/*genetics